京新药业
(002020)
| 流通市值：85.79亿 | | | 总市值：102.03亿 |
| 流通股本：7.24亿 | | | 总股本：8.61亿 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 3,035,689,121.01 | 1,987,184,442.18 | 923,034,058.55 | 4,069,361,419.58 |
| 营业总成本 | 2,402,725,597.87 | 1,550,664,535.52 | 738,160,639.57 | 3,228,447,527.92 |
| 其他经营收益 | | | | |
| 营业利润 | 635,911,077.44 | 420,539,763.6 | 194,131,533.44 | 862,654,942.4 |
| 利润总额 | 625,254,704.62 | 412,531,646.86 | 191,374,366.42 | 864,325,602.05 |
| 净利润 | 532,704,548.38 | 355,950,434.85 | 166,150,235.51 | 766,667,967.92 |
| 每股收益 | | | | |
| 其他综合收益 | -360,585.14 | 282,436.32 | 209,371.89 | -91,596.05 |
| 综合收益总额 | 532,343,963.24 | 356,232,871.17 | 166,359,607.4 | 766,576,371.87 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 3,796,524,446.72 | 3,893,508,196.19 | 3,192,592,294.78 | 3,300,802,355.47 |
| 非流动资产: | | | | |
| 非流动资产合计 | 4,319,101,673.2 | 4,059,161,502.31 | 4,865,457,515.15 | 4,822,729,078.39 |
| 资产总计 | 8,115,626,119.92 | 7,952,669,698.5 | 8,058,049,809.93 | 8,123,531,433.86 |
| 流动负债: | | | | |
| 流动负债合计 | 1,727,289,195.62 | 1,568,864,575.44 | 1,572,078,247.03 | 1,906,909,059.03 |
| 非流动负债: | | | | |
| 非流动负债合计 | 343,618,444.25 | 345,431,101.75 | 353,900,688.43 | 346,354,873.09 |
| 负债合计 | 2,070,907,639.87 | 1,914,295,677.19 | 1,925,978,935.46 | 2,253,263,932.12 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 6,005,307,778.84 | 6,000,304,415.05 | 6,093,894,330.6 | 5,833,037,935.52 |
| 股东权益合计 | 6,044,718,480.05 | 6,038,374,021.31 | 6,132,070,874.47 | 5,870,267,501.74 |
| 负债和股东权益合计 | 8,115,626,119.92 | 7,952,669,698.5 | 8,058,049,809.93 | 8,123,531,433.86 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 3,117,028,112.82 | 2,034,436,535.87 | 982,794,705.18 | 3,946,293,309.77 |
| 经营活动现金流出小计 | 2,349,540,854.57 | 1,557,524,494.68 | 800,938,239.21 | 3,164,946,236.93 |
| 经营活动产生的现金流量净额 | 767,487,258.25 | 476,912,041.19 | 181,856,465.97 | 781,347,072.84 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 3,805,168,242.33 | 2,656,395,214.49 | 1,660,156,516.01 | 2,740,947,150.05 |
| 投资活动现金流出小计 | 4,335,969,986.33 | 2,807,374,029.02 | 1,955,847,474.72 | 2,373,841,173.93 |
| 投资活动产生的现金流量净额 | -530,801,744 | -150,978,814.53 | -295,690,958.71 | 367,105,976.12 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 364,159,979.82 | 258,444,018.42 | 89,042,500 | 567,346,679.45 |
| 筹资活动现金流出小计 | 769,504,993.36 | 603,261,690.29 | 86,744,654.88 | 1,483,095,603.54 |
| 筹资活动产生的现金流量净额 | -405,345,013.54 | -344,817,671.87 | 2,297,845.12 | -915,748,924.09 |
| 汇率变动对现金及现金等价物的影响 | -20,882,722.73 | -16,558,377.64 | -10,431,386.1 | -7,217,125.84 |
| 现金及现金等价物净增加额 | -189,542,222.02 | -35,442,822.85 | -121,968,033.72 | 225,486,999.03 |
| 期末现金及现金等价物余额 | 323,089,709.71 | 477,189,108.88 | 390,707,298.98 | 512,631,931.73 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -35,442,822.85 | - | 225,486,999.03 |
最新报告期：2026-10-12| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 东吴证券 | 朱国广 | 0.96 | 1.09 | 1.23 | 2026-10-12 |
| 西部证券 | 李梦园 | 0.98 | 1.12 | 1.24 | 2026-09-05 |
| 平安证券 | 叶寅,曹艳凯,韩盟盟 | 0.92 | 1.03 | 1.12 | 2026-09-03 |
| 东方证券 | 伍云飞,胡俊涛 | 0.91 | 1.07 | 1.24 | 2026-08-30 |